|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Urine os- molality, cyclic AMP anaquaporin - 2 in urine of patients under lithium treatment in response to water loading fol- lowed by vasopressin administration 显示文摘 | Wilting I Baumgarten R Movig K L | 2007 | European Jour- nal of Pharmacology2007，566，13： | 1 |
| 2 | Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinsons disease显示文摘 | ARBOU W M E L MOVIG K L L EGBERTS T C G POELS P J E VAN VUGT J P P WESSELS J A M VAN DER STRAATEN R J H M NEEF C GUCHELAAR H J | 2009 | Eur J Clin Pharm2009，65，12： | 1 |
| 3 | Serotonergic antidepressants associated with an increased risk for hyponatremia in the elderly显示文摘 | Movig K L Leufkens H G Lenderink A W | 2002 | Eur J Clin Pharmacol2002，58，2： | 1 |
| 4 | Glycopyrrolate for sialorrhea in Parkinson disease:a randomized,double-blind,crossover trial显示文摘 | Arbouw ME Movig KL Koopmann M | | 0，，： | 1 |
| 5 | Serotonergic anti- depressants associated with an increased risk for hyponatraemia in the elderly显示文摘 | Movig KL Leufkens HG Lendefink AW | 2002 | Eur J Clin Pharmacol2002，58，2： | 1 |
| 6 | Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high - performance liquid chromatography 显示文摘 | Movig KLL Langen MCJ Egberts ACG | 1999 | J Pharm Biomed Analy1999，21，： | 1 |
| 7 | Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson' s disease显示文摘 | Arbouw M E L Movig K L L Egberts T C G | 2009 | Eur J Clin Pharmacol2009，65，： | 1 |
| 8 | Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study显示文摘 | I. L. Meek H. E. Vonkeman J. Kasemier K. L. L. Movig M. A. F. J. Laar | 2013 | European Journal of Clinical Pharmacology2013，，3： | 1 |
| 9 | Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial显示文摘 | M.E.L. Arbouw K.L.L. Movig M. Koopmann P.J.E. Poels H.-J. Guchelaar T.C.G. Egberts C. Neef J.P.P. van Vugt | 2010 | Neurology2010，，15： | 1 |
| 10 | Urine osmolality,cyclicAMP anaquaporin-2 in urine of patients under lithium treatment inresponse to water loading followed by vasopressin administration显示文摘 | Wilting I Baumgarten R Movig KL | 2007 | Eur J Pharmacol2007，566，13： | 1 |
| 11 | Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease 显示文摘 | Arbouw MEL Movig KLL Egberts TCG | 2009 | Eur J Clin Pharmacol2009，65，： | 1 |
| 12 | Urine osmolal-ity,cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration显示文摘 | Wilting I Baumgarten R Movig KL | 2007 | Eur J Pharmacol2007，566，13： | 1 |
| 13 | Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatography 显示文摘 | Movig KL Langen MC Egberts AC | 1999 | J Pham Biomed Anal1999，21，4： | 1 |
| 14 | Psychoactive substance use and the risk of motor vehicle accidents 显示文摘 | MOVIG K L MATHIJSSEN M P NAGEL P H | 2004 | Accid Anal Prey2004，36，4： | 1 |
| 15 | Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double- blind, crossover trial显示文摘 | Arbouw ME Movig KL Koopmann M | 2010 | Neurology2010，74，15： | 1 |
| 16 | Psychoactive substance use and the risk of motor vehicle accidents显示文摘 | Movig KL Mathijssen MP Nagel PH | 2004 | Accid Anal Prey2004，36，： | 1 |
| 17 | Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treament in response to water loading followde byyasopressin ad- ministration显示文摘 | Wilting I Baumgarten R Movig KL | 2007 | Eur J Pharmacol2007，566，13： | 1 |
| 18 | Psychoactive substance use and the risk of motor vehicle accidents 显示文摘 | Movig KL Methijssen MP Nagd PH | 2004 | Accid Anal Prey2004，36，4： | 1 |
| 19 | Dopami nergic drugs and the risk of hip or femur fracture:a population-based case-control study显示文摘 | Arbouw ME Movig KL van Staa TP | 2011 | Osteoporosis International2011，22，6： | 1 |
| 20 | Urine osmolality,cyclic AMP anaquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration显示文摘 | Wilting I Baumgarten R Movig KL | 2007 | Eur J Pharmacol2007，566，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员